These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9450764)

  • 1. Isolation and characterization of an oligodendrocyte precursor-derived B-cell epitope in multiple sclerosis.
    Archelos JJ; Trotter J; Previtali S; Weissbrich B; Toyka KV; Hartung HP
    Ann Neurol; 1998 Jan; 43(1):15-24. PubMed ID: 9450764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study.
    Lily O; Palace J; Vincent A
    Brain; 2004 Feb; 127(Pt 2):269-79. PubMed ID: 14662514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness.
    Link H; Huang YM
    J Neuroimmunol; 2006 Nov; 180(1-2):17-28. PubMed ID: 16945427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis.
    Qin Y; Duquette P; Zhang Y; Talbot P; Poole R; Antel J
    J Clin Invest; 1998 Sep; 102(5):1045-50. PubMed ID: 9727074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The study of anti-oligodendrocyte antibody in sera, and CSF of patients with multiple sclerosis].
    Hirayama M; Kawai K; Iida M
    Rinsho Shinkeigaku; 1990 Mar; 30(3):262-5. PubMed ID: 2364627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of autoimmunity to transaldolase in multiple sclerosis.
    Niland B; Perl A
    Methods Mol Med; 2004; 102():155-71. PubMed ID: 15286385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-reactive idiotypy in cerebrospinal fluid immunoglobulins in multiple sclerosis.
    LaGanke CC; Freeman DW; Whitaker JN
    Ann Neurol; 2000 Jan; 47(1):87-92. PubMed ID: 10632105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of immunoglobulins and B cells in multiple sclerosis: from pathogenesis to treatment.
    Antel J; Bar-Or A
    J Neuroimmunol; 2006 Nov; 180(1-2):3-8. PubMed ID: 16934338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese.
    Matsuoka T; Matsushita T; Kawano Y; Osoegawa M; Ochi H; Ishizu T; Minohara M; Kikuchi H; Mihara F; Ohyagi Y; Kira J
    Brain; 2007 May; 130(Pt 5):1206-23. PubMed ID: 17439988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid T cell clones from patients with multiple sclerosis: recognition of idiotopes on monoclonal IgG secreted by autologous cerebrospinal fluid B cells.
    Holmøy T; Fredriksen AB; Thompson KM; Hestvik AL; Bogen B; Vartdal F
    Eur J Immunol; 2005 Jun; 35(6):1786-94. PubMed ID: 15864781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligoclonal bands and antibody responses in multiple sclerosis.
    Correale J; de los Milagros Bassani Molinas M
    J Neurol; 2002 Apr; 249(4):375-89. PubMed ID: 11967640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid immunoglobulin G promotes oligodendrocyte progenitor cell migration.
    Tiwari-Woodruff SK; Myers LW; Bronstein JM
    J Neurosci Res; 2004 Aug; 77(3):363-6. PubMed ID: 15248292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligodendrocyte staining by multiple sclerosis serum is nonspecific.
    Traugott U; Snyder S; Raine CS
    Ann Neurol; 1979 Jul; 6(1):13-20. PubMed ID: 389147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis.
    Obermeier B; Mentele R; Malotka J; Kellermann J; Kümpfel T; Wekerle H; Lottspeich F; Hohlfeld R; Dornmair K
    Nat Med; 2008 Jun; 14(6):688-93. PubMed ID: 18488038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune-mediated oligodendrocyte injury in multiple sclerosis: molecular mechanisms and therapeutic interventions.
    Buntinx M; Stinissen P; Steels P; Ameloot M; Raus J
    Crit Rev Immunol; 2002; 22(5-6):391-424. PubMed ID: 12803318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular approach to find target(s) for oligoclonal bands in multiple sclerosis.
    Rand KH; Houck H; Denslow ND; Heilman KM
    J Neurol Neurosurg Psychiatry; 1998 Jul; 65(1):48-55. PubMed ID: 9667560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificities of multiple sclerosis cerebrospinal fluid and serum antibodies against mimotopes.
    Jolivet-Reynaud C; Perron H; Ferrante P; Becquart L; Dalbon P; Mandrand B
    Clin Immunol; 1999 Dec; 93(3):283-93. PubMed ID: 10600340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonally expanded plasma cells in the cerebrospinal fluid of MS patients produce myelin-specific antibodies.
    von Büdingen HC; Harrer MD; Kuenzle S; Meier M; Goebels N
    Eur J Immunol; 2008 Jul; 38(7):2014-23. PubMed ID: 18521957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies reactive to heat shock protein 90 induce oligodendrocyte precursor cell death in culture. Implications for demyelination in multiple sclerosis.
    Cid C; Alvarez-Cermeño JC; Camafeita E; Salinas M; Alcázar A
    FASEB J; 2004 Feb; 18(2):409-11. PubMed ID: 14688203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human transaldolase and cross-reactive viral epitopes identified by autoantibodies of multiple sclerosis patients.
    Esposito M; Venkatesh V; Otvos L; Weng Z; Vajda S; Banki K; Perl A
    J Immunol; 1999 Oct; 163(7):4027-32. PubMed ID: 10491006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.